Page last updated: 2024-08-21

oleanolic acid and Cystic Fibrosis

oleanolic acid has been researched along with Cystic Fibrosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Davis, PB; Eastman, JF; Nichols, DP; Shank, SL; Ziady, AG	1

Other Studies

1 other study(ies) available for oleanolic acid and Cystic Fibrosis

Article	Year
The triterpenoid CDDO limits inflammation in preclinical models of cystic fibrosis lung disease. American journal of physiology. Lung cellular and molecular physiology, 2009, Volume: 297, Issue:5 Topics: Animals; Antioxidants; Bronchi; Bronchoalveolar Lavage; Cell Line; Cell Proliferation; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Epithelial Cells; Flagellin; Humans; Inflammation; Inflammation Mediators; Interleukin-8; Lipopolysaccharides; Mice; Neutrophils; NF-E2-Related Factor 2; NF-kappa B; Oleanolic Acid; Oxidation-Reduction; Proteomics; Trachea; Triterpenes	2009

Article

Year

The triterpenoid CDDO limits inflammation in preclinical models of cystic fibrosis lung disease.

American journal of physiology. Lung cellular and molecular physiology, 2009, Volume: 297, Issue:5

Topics: Animals; Antioxidants; Bronchi; Bronchoalveolar Lavage; Cell Line; Cell Proliferation; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Epithelial Cells; Flagellin; Humans; Inflammation; Inflammation Mediators; Interleukin-8; Lipopolysaccharides; Mice; Neutrophils; NF-E2-Related Factor 2; NF-kappa B; Oleanolic Acid; Oxidation-Reduction; Proteomics; Trachea; Triterpenes

2009